Physician profile
Narendra R Kumar
NPI 1598704892
$3,226.11
in general payments reported to CMS, 2019-2025
12 companies · $917 in 2025
The $917 reported for 2025 was more than what 87% of Plastic Surgery Within The Head & Neck providers received nationally (typical 2025 total: $238).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.37 · 2020: $322 · 2021: $205 · 2022: $313 · 2023: $813 · 2024: $581 · 2025: $917.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,221 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,221.28 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $1,335.61 | 2019-2025 | |
| Axsome Therapeutics, INC. | $605.02 | 2023-2025 | Sunosi |
| Harmony Biosciences LLC | $447.99 | 2022-2025 | Wakix |
| Eisai INC. | $227.92 | 2020-2022 | |
| Idorsia Pharmaceuticals US INC | $181.77 | 2022-2024 | Quviviq |
| Avadel Cns Pharmaceuticals, LLC | $150.00 | 2025 | Lumryz |
| 3b Medical, INC. | $81.55 | 2023 | Luna |
| Resmed Corp | $68.38 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $44.68 | 2023 | Belsomra |
| Inspire Medical Systems, INC. | $42.35 | 2024 | Inspire |
| Boston Scientific Corporation | $24.03 | 2023 | Varithena Administration Pack |
| Zoll Respicardia, INC. | $16.81 | 2023 | Remede System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Narendra Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.